3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
17
Biliary Tract Neoplasms
4
Pancreatic Neoplasms
3
Adenocarcinoma
3
Neoplasms
2
Esophageal Neoplasms
2
Cholangiocarcinoma
2
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic cancer, adult
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
NSCLC
1
Locally Advanced Gastric or Gastroesophageal Junction Cancer
1
Locally Advanced Gastric Cancer
1
Klatskin Tumor
1
Gastric Cancer Peritoneal Metastases
1
Gastric Adenocarcinoma
1
Gallbladder Neoplasms
1
Colorectal Neoplasms
1
Chemotherapy Effect
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Bile Duct Neoplasms
1
Interventions
Cisplatin
26
Paclitaxel
21
pembrolizumab
15
Radiotherapy
13
Carboplatin
13
tislelizumab
12
Fluorouracil
12
Drug Therapy
11
Irinotecan
9
toripalimab
8
Esophagectomy
8
Oxaliplatin
6
Nivolumab
6
Capecitabine
6
Neoadjuvant Therapy
5
Leucovorin
5
Docetaxel
5
lenvatinib
4
camrelizumab
4
Taxes
4
Radiation
4
Levoleucovorin
4
Immune Checkpoint Inhibitors
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
spartalizumab
3
sintilimab
3
apatinib
3
Itraconazole
3
Injections
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
S 1 (combination)
×
1 year
×
Clear all
No trials found.